One in four patients say they've skimped on insulin because of high cost

(Yale University) For patients with diabetes, insulin is a life-saving medicine and an essential component of diabetes management, yet in the past decade alone, the out-of-pocket costs for insulin have doubled in the United States. One-quarter of patients with type 1 or 2 diabetes have reported using less insulin than prescribed due to these high costs, Yale researchers write in JAMA Internal Medicine, and over a third of those patients experiencing cost-related underuse said they never discussed this reality with their provider.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2FXMX0q